Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7349072

CC(C)COC(=O)N[C@@H](C)C(=O)O.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
PLG P00747 1/20 0.43
PLAU P00749 1/20 0.43
TYR P14679 1/20 0.38
ITGB3 P05106 2/20 0.37
ITGA2B P08514 1/20 0.37
CAPN1 P07384 1/20 0.37
ALDH1A1 P00352 2/20 0.36
LMNA P02545 2/20 0.36
ITGAV P06756 1/20 0.35
TSHR P16473 4/20 0.34
MME P08473 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HTT P42858 2/20 0.33
CTSK P43235 1/20 0.33
ACE P12821 1/20 0.33
CPA1 P15085 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8079441 0.89 SMN1; SMN2 (0.50) SMN1; SMN2TYRALDH1A1LMNATSHR
SCHEMBL18190838 0.89 SMN1; SMN2 (0.50) SMN1; SMN2TYRALDH1A1LMNATSHR
SCHEMBL8079436 0.89 SMN1; SMN2 (0.50) SMN1; SMN2TYRALDH1A1LMNATSHR
SCHEMBL12514588 0.78 PLG (0.48) SMN1; SMN2PLGPLAUCAPN1MME
SCHEMBL27904272 0.77 HTT (0.44) SMN1; SMN2TYRCAPN1ALDH1A1LMNA
SCHEMBL12513815 0.76 CTSK (0.43) SMN1; SMN2PLGPLAUCAPN1MME
Trifluoroacetic Acid SCHEMBL2367570 0.76 CAPN1 (0.58) ITGB3ITGA2BCAPN1ALDH1A1LMNA
Trifluoroacetic Acid SCHEMBL28068720 0.74 TSHR (0.41) SMN1; SMN2PLGPLAUALDH1A1LMNA
SCHEMBL2234718 0.74 MME (0.53) SMN1; SMN2PLGPLAUTYRITGB3
SCHEMBL18190834 0.74 ALDH1A1 (0.58) SMN1; SMN2TYRALDH1A1LMNAMME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998043962-A1 HETEROCYCLIC INTEGRIN INHIBITOR PRODRUGS DU PONT PHARMACEUTICALS COMPANY (US) 1998-10-08 WO disclosed